潜在的B型肝炎感染が自己免疫性肝炎治療の結果に及ぼす影響
Sami Bahcebası1, Nuh Mehmet Büyükberber2, Osman Saglam3
1Internal Medicine, Kayseri City Training and Research Hospital, Kayseri, TUR.
Cureus
|September 2, 2025
まとめ
自己免疫性肝炎 (AIH) の患者における潜在的B型肝炎ウイルス (HBV) 感染は,治療への反応を低下させる. AIH管理のより良い結果のために,潜伏HBVのスクリーニングと抗ウイルス予防の検討が推奨されます.
科学分野:
- ヘパトロジー
- 免疫学
- ウイルス学
背景:
- 自己免疫性肝炎 (AIH) は,免疫抑制療法を必要とする慢性肝疾患である.
- AIH患者における隠されたまたは潜伏したB型肝炎ウイルス (HBV) 感染の存在は完全に理解されていません.
- 潜在的HBVはAIHにおける治療反応と疾患進行に影響を与える可能性があります.
研究 の 目的:
- AIH患者の治療反応に対する潜在的HBV感染の影響を調査する.
- 潜伏性HBV患者および非潜伏性HBV患者における疾患進行マーカーの評価.
主な方法:
- 36人のB型肝炎表面抗原 (HBsAg) 陰性AIH患者の遡及分析
- 潜伏のHBVを特定するために,抗HBc免疫グロブリンG (IgG) 状態に基づいて分類する.
- 肝機能マーカーの診断と免疫抑制療法1年後の評価
主要な成果:
- AIH患者の36. 1%が潜伏したHBV感染 (抗HBcIgG陽性) の証拠を示した.
- 潜伏性HBV患者では,免疫抑制療法に対する生化学反応が低下した.
- 肝臓酵素の持続的な上昇と肝臓機能障害マーカーが潜伏性HBV患者で観察されました.
結論:
- 潜在的HBV感染はAIHにおける治療効果を著しく低下させる.
- 免疫抑制を開始する前に,AIH患者における潜伏性HBVの総合的なスクリーニングが不可欠です.
- 潜伏性HBVの患者では,治療結果を改善するために抗ウイルス予防を考慮する必要があります.
さらに関連する動画
10:37Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix
Published on: October 20, 2021
3.0K
11:36Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms
Published on: May 29, 2020
3.1K
関連する概念動画
Myasthenia Gravis: Overview and Treatment
1.9K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.9K
Autoimmune Disorders
667
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
667
Pulmonary Tuberculosis I
321
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
321
Pulmonary Tuberculosis II
343
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
343
Pulmonary Tuberculosis V
237
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
237
